EP1261735A4 - VERFAHREN UND MATERIALIEN BEZüGLICH LEUKOZYTEN IMMUNGLOBULINREZEPTOR äHNLICHEN (LIR-äHNLICH) POLYPEPTIDEN UND POLYNUKLEOTIDEN - Google Patents

VERFAHREN UND MATERIALIEN BEZüGLICH LEUKOZYTEN IMMUNGLOBULINREZEPTOR äHNLICHEN (LIR-äHNLICH) POLYPEPTIDEN UND POLYNUKLEOTIDEN

Info

Publication number
EP1261735A4
EP1261735A4 EP01905085A EP01905085A EP1261735A4 EP 1261735 A4 EP1261735 A4 EP 1261735A4 EP 01905085 A EP01905085 A EP 01905085A EP 01905085 A EP01905085 A EP 01905085A EP 1261735 A4 EP1261735 A4 EP 1261735A4
Authority
EP
European Patent Office
Prior art keywords
lir
polynucleotides
polypeptides
immunoglobulin receptor
leukocyte immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01905085A
Other languages
English (en)
French (fr)
Other versions
EP1261735A2 (de
Inventor
Bryan J Boyle
Chiauyun Kuo
Nancy K Mize
Dana A Haley
Matthew C Arterburn
Y Tom Tang
Ping Zhou
Chenghua Liu
Vinod Asundi
Radoje T Drmanac
George Yeung
Servando Palencia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1261735A2 publication Critical patent/EP1261735A2/de
Publication of EP1261735A4 publication Critical patent/EP1261735A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP01905085A 2000-01-25 2001-01-25 VERFAHREN UND MATERIALIEN BEZüGLICH LEUKOZYTEN IMMUNGLOBULINREZEPTOR äHNLICHEN (LIR-äHNLICH) POLYPEPTIDEN UND POLYNUKLEOTIDEN Withdrawn EP1261735A4 (de)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US642610 1996-05-03
US49140400A 2000-01-25 2000-01-25
US491404 2000-01-25
US49691400A 2000-02-03 2000-02-03
US496914 2000-02-03
US51970500A 2000-03-07 2000-03-07
US519705 2000-03-07
US56087500A 2000-04-27 2000-04-27
US560875 2000-04-27
US524454 2000-05-19
US64261000A 2000-08-17 2000-08-17
US75151800A 2000-12-29 2000-12-29
US751518 2000-12-29
PCT/US2001/002570 WO2001055335A2 (en) 2000-01-25 2001-01-25 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides

Publications (2)

Publication Number Publication Date
EP1261735A2 EP1261735A2 (de) 2002-12-04
EP1261735A4 true EP1261735A4 (de) 2005-04-06

Family

ID=46397760

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01905085A Withdrawn EP1261735A4 (de) 2000-01-25 2001-01-25 VERFAHREN UND MATERIALIEN BEZüGLICH LEUKOZYTEN IMMUNGLOBULINREZEPTOR äHNLICHEN (LIR-äHNLICH) POLYPEPTIDEN UND POLYNUKLEOTIDEN

Country Status (4)

Country Link
EP (1) EP1261735A4 (de)
AU (2) AU2001233003B2 (de)
CA (1) CA2398251A1 (de)
WO (1) WO2001055335A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532256A (ja) * 2001-11-14 2005-10-27 イミユネツクス・コーポレイシヨン 慢性関節リウマチを治療するためのｌｉｒ機能の調節
AU2002952993A0 (en) * 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
US20080248011A1 (en) * 2004-01-27 2008-10-09 Medical And Biological Laboratories Co., Ltd. Methods for Isolating Monocytes
NZ567043A (en) * 2005-09-29 2012-08-31 Eisai R&D Man Co Ltd T-cell adhesion molecule and antibody thereto for inhibiting interaction between TARM and TARM-L
WO2011091177A1 (en) 2010-01-20 2011-07-28 Tolerx, Inc. Anti-ilt5 antibodies and ilt5-binding antibody fragments
EP2525822B1 (de) 2010-01-20 2017-05-10 Merck Sharp & Dohme Corp. Immunregulierung durch antikörper gegen ilt5 und ilt5-bindende antikörper-fragmente
US10743538B2 (en) 2014-10-01 2020-08-18 Plant Health Care, Inc. Elicitor peptides having disrupted hypersensitive response box and use thereof
CN107002091A (zh) 2014-10-01 2017-08-01 植物保健公司 过敏反应激发子肽及其用途
BR112018069945A2 (pt) 2016-04-06 2019-02-05 Plant Health Care, Inc. micróbios benéficos para distribuição de peptídeos ou proteínas efetoras e uso dos mesmos
PL3439682T3 (pl) 2016-04-06 2025-12-01 Plant Health Care, Inc. Peptydy pochodzące od czynnika wywołującego odpowiedź nadwrażliwości i ich stosowanie

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998031806A2 (en) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Fc RECEPTORS AND POLYPEPTIDES
WO1998045435A2 (en) * 1997-04-10 1998-10-15 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
WO1998048017A1 (en) * 1997-04-24 1998-10-29 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
EP0897981A1 (de) * 1997-08-19 1999-02-24 Smithkline Beecham PIGR-1, ein Mitglied der Immunglobulingensuperfamilie
EP0905237A2 (de) * 1997-08-25 1999-03-31 Smithkline Beecham Corporation PIGR-2 ein Mitglied der Immunglobulingen-Superfamilie
WO2000047602A1 (en) * 1999-02-10 2000-08-17 Human Genome Sciences, Inc. 33 human secreted proteins
WO2001000673A1 (en) * 1999-06-30 2001-01-04 Millennium Pharmaceuticals, Inc. Membrane-associated and secreted proteins and uses thereof
WO2001012662A2 (en) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Membrane associated proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078962A1 (en) * 1999-06-18 2000-12-28 Immunex Corporation Lsr, a cdna of the ig superfamily expressed in human leukocytes

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998031806A2 (en) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Fc RECEPTORS AND POLYPEPTIDES
WO1998045435A2 (en) * 1997-04-10 1998-10-15 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
WO1998048017A1 (en) * 1997-04-24 1998-10-29 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
EP0897981A1 (de) * 1997-08-19 1999-02-24 Smithkline Beecham PIGR-1, ein Mitglied der Immunglobulingensuperfamilie
EP0905237A2 (de) * 1997-08-25 1999-03-31 Smithkline Beecham Corporation PIGR-2 ein Mitglied der Immunglobulingen-Superfamilie
WO2000047602A1 (en) * 1999-02-10 2000-08-17 Human Genome Sciences, Inc. 33 human secreted proteins
WO2001000673A1 (en) * 1999-06-30 2001-01-04 Millennium Pharmaceuticals, Inc. Membrane-associated and secreted proteins and uses thereof
WO2001012662A2 (en) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Membrane associated proteins

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
COLONNA M ET AL: "A NOVEL FAMILY OF IG-LIKE RECEPTORS FOR HLA CLASS I MOLECULES THAT MODULATE FUNCTION OF LYMPHOID AND MYELOID CELLS", JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL, US, vol. 66, no. 3, September 1999 (1999-09-01), pages 375 - 381, XP008031825, ISSN: 0741-5400 *
DATABASE EMBL EBI; 14 December 1999 (1999-12-14), BIRREN B., NUSBAUM C., LANDER E.: "Homo sapiens chromosome 17, clone RP11-452I5, complete sequence.", XP002302980, Database accession no. AC016888 *
DATABASE EMBL EBI; 26 September 1996 (1996-09-26), TOYABE S.: "Homo sapiens mRNA for CD89_U11, complete cds.", XP002302968, Database accession no. D87855 *
DATABASE GENEBANK NCBI; 1 January 1997 (1997-01-01), ROJO, S. ET AL.: "Human putative inhibitory receptor mRNA partial cds.", XP002302966, Database accession no. U70665 *
DATABASE Geneseq DERWENT; 27 April 1999 (1999-04-27), JACOBS K. ET AL. (GENETICS INST INC.): "EST clone O47.", XP002302981, Database accession no. AAV86215 *
DATABASE UniProt 1 October 1996 (1996-10-01), JACKSON D.G. ET AL.: "CMRF-35A antigen precursor (CMRF-35)", XP002302967, Database accession no. Q08708 *
JACKSON D G ET AL: "MOLECULAR CLONING OF A NOVEL MEMBER OF THE IMMUNOGLOBULIN GENE SUPERFAMILY HOMOLOGOUS TO THE POLYMERIC IMMUNOGLOBULIN RECEPTOR", EUROPEAN JOURNAL OF IMMUNOLOGY, WEINHEIM, DE, vol. 22, no. 5, 1992, pages 1157 - 1163, XP000972369, ISSN: 0014-2980 *
ROJO S ET AL: "Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 JAN 1997, vol. 158, no. 1, 1 January 1997 (1997-01-01), pages 9 - 12, XP002074918, ISSN: 0022-1767 *
See also references of WO0155335A3 *

Also Published As

Publication number Publication date
AU3300301A (en) 2001-08-07
EP1261735A2 (de) 2002-12-04
WO2001055335A3 (en) 2002-03-07
CA2398251A1 (en) 2001-08-02
WO2001055335A2 (en) 2001-08-02
AU2001233003B2 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
DE60209455D1 (de) Selbst-füllende Zementierschleuse und Verfahren
DK3095793T3 (da) Reducering af udvaskning af protein A under en protein A-affinitetskromatografi
ATE360070T1 (de) Rezeptor-nukleinsäure und rezeptor-polypeptide
ATE510555T1 (de) Chemisch modifizierte neue erythropoietin- stimulierende protein zusammensetzungen und verfahren
DE60223757D1 (de) Buchbindevorrichtung und Verfahren
DK1036179T3 (da) Fremgangsmåde til fremstilling af polypeptider med egnet glucosilering
EP1556490A4 (de) Neue nukleinsäuren und polypeptide
EP1244447A4 (de) Neue verfahren und zubereitungen die opioiden und deren antagonisten enthalten
DE69623794D1 (de) Hubanker zum einbetten in betonteilen
EP1252333A4 (de) Verfahren und Materialien mit Bezug zu CD84-ähnlichen Polypeptiden und Polynukleotiden
EP1325120A4 (de) Neue nukleinsäuren und polypeptide
AU8743001A (en) Moraxella polypeptides and corresponding dna fragments and uses thereof
EP1250346A4 (de) Verfahren und ausgangsprodukte in bezug auf g-protein gekoppelte rezeptorähnliche polypeptide und polynukleotide
ATE218534T1 (de) Substituierte aminoverbindungen und ihre verwendung als analgetisch wirksame substanzen
DE60216840D1 (de) Verfahren zum Abdichten von keramischen Wabenkörpern
NO20040249L (no) Blodgruppeantigenfusjonspolypeptider og fremgangsmater for deres anvendelse
EP1276751A4 (de) Neue nukleinsäuren und polypeptide
DE60236721D1 (de) Verfahren zum verknüpfen von schlauchförmigen maschenwaren und dafür geeignete maschenware
EP1483386A4 (de) Neue nukleinsäuren und abgesonderte polypeptide
AU3300301A (en) Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
DE60113837D1 (de) Verfahren zum stabilisieren von verbundmaterialien und durch dieses verfahren hergestellte materialien
EP1409655A4 (de) Proteine der immunglobulin-superfamilie
IS6940A (is) Aðferð og tæki til að aðgreina brot í efnisflæði
EP1341803A4 (de) Neue nukleinsäuren und polypeptide
DE69532230T2 (de) Verfahren und Vorrichtung zum Sintern von Zementklinkern

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020826

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KUO, CHIAUYUN

Inventor name: LIU, CHENGHUA

Inventor name: ARTERBURN, MATTHEW, C.

Inventor name: ZHOU, PING

Inventor name: MIZE, NANCY, K.

Inventor name: TANG, Y., TOM

Inventor name: HALEY, DANA, A.

Inventor name: BOYLE, BRYAN, J.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07H 21/02 B

Ipc: 7C 12Q 1/68 A

Ipc: 7C 07K 14/705 B

Ipc: 7A 61K 38/00 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050221

17Q First examination report despatched

Effective date: 20050620

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20081008